Redirecting to original paper in 30 seconds...
Click below to go immediately or wait for automatic redirect
📄 Abstract
Abstract: Designing de novo 3D molecules with desirable properties remains a
fundamental challenge in drug discovery and molecular engineering. While
diffusion models have demonstrated remarkable capabilities in generating
high-quality 3D molecular structures, they often struggle to effectively
control complex multi-objective constraints critical for real-world
applications. In this study, we propose an uncertainty-aware Reinforcement
Learning (RL) framework to guide the optimization of 3D molecular diffusion
models toward multiple property objectives while enhancing the overall quality
of the generated molecules. Our method leverages surrogate models with
predictive uncertainty estimation to dynamically shape reward functions,
facilitating balance across multiple optimization objectives. We
comprehensively evaluate our framework across three benchmark datasets and
multiple diffusion model architectures, consistently outperforming baselines
for molecular quality and property optimization. Additionally, Molecular
Dynamics (MD) simulations and ADMET profiling of top generated candidates
indicate promising drug-like behavior and binding stability, comparable to
known Epidermal Growth Factor Receptor (EGFR) inhibitors. Our results
demonstrate the strong potential of RL-guided generative diffusion models for
advancing automated molecular design.
Authors (4)
Lianghong Chen
Dongkyu Eugene Kim
Mike Domaratzki
Pingzhao Hu
Submitted
October 24, 2025
Key Contributions
This paper proposes an uncertainty-aware Reinforcement Learning (RL) framework to guide 3D molecular diffusion models for multi-objective optimization. By leveraging surrogate models with predictive uncertainty, it dynamically shapes reward functions to balance multiple property objectives while improving generated molecule quality, outperforming baselines in molecular design.
Business Value
Accelerates the drug discovery and materials science pipelines by enabling the rapid design of novel molecules with specific, complex properties, potentially reducing R&D costs and time.